We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s approval of a new DNA microarray test will allow doctors to screen a patient’s genetic information to select medications and doses for a variety of common illnesses.